Alleviare India Logo


A drug used with other drugs to treat acute myeloid leukemia that is newly diagnosed. If you have question, please e-mail Allevaire Indian Team or call Allevaire Network on +91-9818274099 (Mr. Kamal Kaushal) for further details.

Venclexta is also used to treat chronic lymphocytic leukemia and small lymphocytic lymphoma in adults

Venclexta is a brand-name prescription medication. It’s used to treat certain cancers that affect your blood cells. Venclexta is FDA-approved to treat:

Chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in adults. CLL and SLL affect white blood cells called B cells. With SLL, the cancer cells are mainly in the lymph nodes. With CLL, the cancer cells are mainly in the blood and bone marrow.

Newly diagnosed acute myeloid leukemia (AML) in adults ages 75 years or older, or in adults who can’t have standard chemotherapy. AML affects myeloid cells. These are cells in your bone marrow that normally develop into red blood cells, white blood cells, and platelets.

Venclyxta (Venetoclax) Medicine suppliers in India. Allevaire India New Delhi, INDIA.

Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.

The order for Venclyxta (Venetoclax) Medicine will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

VENCLEXTA is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), with or without 17p deletion, who have received at least one prior therapy.

Uses of Venclyxta (Venetoclax) Medicine:

This medication is used to treat certain types of cancer (chronic lymphocytic leukemia-CLL, small lymphocytic lymphoma-SLL, acute myeloid leukemia-AML). Venetoclax is a chemotherapy drug that works by slowing or stopping the growth of cancer cells.

Medicine Name: Venclyxta
Generic Name: Venetoclax
Approval Date: June 8, 2018
Company Name: AbbVie Inc.

Available as (Form & Strength): Venclexta comes as tablets that you take by mouth once a day. It’s available in three strengths: 10 mg, 50 mg, and 100 mg.

vanclyxta 100 mg

Venclyxta (Venetoclax) is available.

Get In Touch

    Venclyxta (Venetoclax) Medicine suppliers in India

    ALS helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Venclyxta (Venetoclax) Medicine on prescription and Import License in Patient’s Name only.

    For foreign countries patients, Venclyxta (Venetoclax) Medicine can be made available in Send your inquiry to find Venclyxta (Venetoclax) Medicine in China, Cambodia, Indonesia the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

    News / Update for Venclyxta (Venetoclax) Medicine

    For Venclyxta (Venetoclax) Medicine Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details